From genome to therapy: integrating new technologies with drug development
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chichester [u.a.]
Wiley
2000
|
| Schriftenreihe: | Novartis Foundation: Novartis Foundation Symposium
229 |
| Schlagworte: | |
| Beschreibung: | VIII, 165 S. Ill., graph. Darst. |
| ISBN: | 0471627445 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV013540695 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 010119s2000 ad|| |||| 10||| eng d | ||
| 020 | |a 0471627445 |9 0-471-62744-5 | ||
| 035 | |a (OCoLC)44548923 | ||
| 035 | |a (DE-599)BVBBV013540695 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-20 | ||
| 050 | 0 | |a RM301.3.G45 | |
| 082 | 0 | |a 615/.19 |2 21 | |
| 245 | 1 | 0 | |a From genome to therapy |b integrating new technologies with drug development |
| 264 | 1 | |a Chichester [u.a.] |b Wiley |c 2000 | |
| 300 | |a VIII, 165 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Novartis Foundation: Novartis Foundation Symposium |v 229 | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Drugs - Design | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Genetische manipulatie |2 gtt | |
| 650 | 4 | |a Human genome | |
| 650 | 4 | |a Pharmacogénomique - Congrès | |
| 650 | 4 | |a Pharmacogénétique - Congrès | |
| 650 | 4 | |a Drug Design |v Congresses | |
| 650 | 4 | |a Genomics |v Congresses | |
| 650 | 4 | |a Pharmacogenetics |v Congresses | |
| 650 | 4 | |a Pharmacogenomics |v Congresses | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakogenetik |0 (DE-588)4271255-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Genanalyse |0 (DE-588)4200230-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1999 |z Basel |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Genanalyse |0 (DE-588)4200230-8 |D s |
| 689 | 1 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 830 | 0 | |a Novartis Foundation: Novartis Foundation Symposium |v 229 |w (DE-604)BV011990857 |9 229 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009245019 | ||
Datensatz im Suchindex
| _version_ | 1804128336919658496 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV013540695 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.3.G45 |
| callnumber-search | RM301.3.G45 |
| callnumber-sort | RM 3301.3 G45 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)44548923 (DE-599)BVBBV013540695 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01906nam a2200541 cb4500</leader><controlfield tag="001">BV013540695</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">010119s2000 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471627445</subfield><subfield code="9">0-471-62744-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)44548923</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013540695</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.3.G45</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">21</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">From genome to therapy</subfield><subfield code="b">integrating new technologies with drug development</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester [u.a.]</subfield><subfield code="b">Wiley</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 165 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Novartis Foundation: Novartis Foundation Symposium</subfield><subfield code="v">229</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs - Design</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genetische manipulatie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human genome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogénomique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogénétique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenetics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenomics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Genanalyse</subfield><subfield code="0">(DE-588)4200230-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1999</subfield><subfield code="z">Basel</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Genanalyse</subfield><subfield code="0">(DE-588)4200230-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Novartis Foundation: Novartis Foundation Symposium</subfield><subfield code="v">229</subfield><subfield code="w">(DE-604)BV011990857</subfield><subfield code="9">229</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009245019</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1999 Basel gnd-content |
| genre_facet | Konferenzschrift 1999 Basel |
| id | DE-604.BV013540695 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:47:38Z |
| institution | BVB |
| isbn | 0471627445 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009245019 |
| oclc_num | 44548923 |
| open_access_boolean | |
| owner | DE-12 DE-20 |
| owner_facet | DE-12 DE-20 |
| physical | VIII, 165 S. Ill., graph. Darst. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Wiley |
| record_format | marc |
| series | Novartis Foundation: Novartis Foundation Symposium |
| series2 | Novartis Foundation: Novartis Foundation Symposium |
| spelling | From genome to therapy integrating new technologies with drug development Chichester [u.a.] Wiley 2000 VIII, 165 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Novartis Foundation: Novartis Foundation Symposium 229 Drug development Drugs - Design Geneesmiddelen gtt Genetische manipulatie gtt Human genome Pharmacogénomique - Congrès Pharmacogénétique - Congrès Drug Design Congresses Genomics Congresses Pharmacogenetics Congresses Pharmacogenomics Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Pharmakogenetik (DE-588)4271255-5 gnd rswk-swf Genanalyse (DE-588)4200230-8 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1999 Basel gnd-content Pharmakogenetik (DE-588)4271255-5 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Genanalyse (DE-588)4200230-8 s Novartis Foundation: Novartis Foundation Symposium 229 (DE-604)BV011990857 229 |
| spellingShingle | From genome to therapy integrating new technologies with drug development Novartis Foundation: Novartis Foundation Symposium Drug development Drugs - Design Geneesmiddelen gtt Genetische manipulatie gtt Human genome Pharmacogénomique - Congrès Pharmacogénétique - Congrès Drug Design Congresses Genomics Congresses Pharmacogenetics Congresses Pharmacogenomics Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd Pharmakogenetik (DE-588)4271255-5 gnd Genanalyse (DE-588)4200230-8 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4271255-5 (DE-588)4200230-8 (DE-588)1071861417 |
| title | From genome to therapy integrating new technologies with drug development |
| title_auth | From genome to therapy integrating new technologies with drug development |
| title_exact_search | From genome to therapy integrating new technologies with drug development |
| title_full | From genome to therapy integrating new technologies with drug development |
| title_fullStr | From genome to therapy integrating new technologies with drug development |
| title_full_unstemmed | From genome to therapy integrating new technologies with drug development |
| title_short | From genome to therapy |
| title_sort | from genome to therapy integrating new technologies with drug development |
| title_sub | integrating new technologies with drug development |
| topic | Drug development Drugs - Design Geneesmiddelen gtt Genetische manipulatie gtt Human genome Pharmacogénomique - Congrès Pharmacogénétique - Congrès Drug Design Congresses Genomics Congresses Pharmacogenetics Congresses Pharmacogenomics Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd Pharmakogenetik (DE-588)4271255-5 gnd Genanalyse (DE-588)4200230-8 gnd |
| topic_facet | Drug development Drugs - Design Geneesmiddelen Genetische manipulatie Human genome Pharmacogénomique - Congrès Pharmacogénétique - Congrès Drug Design Congresses Genomics Congresses Pharmacogenetics Congresses Pharmacogenomics Congresses Arzneimittelentwicklung Pharmakogenetik Genanalyse Konferenzschrift 1999 Basel |
| volume_link | (DE-604)BV011990857 |